96457
Off
Mom's belief teal text logo with a stylized mother and child icon replacing the letter 'o'

Rays of Belief IPO

  • Status: Closed
  • RHP:
  • BSE, NSE
  • ₹ 14,074 / 62 shares

    Minimum Investment

IPO Listing Details

  • Listing Date

    08 Sep 2026

  • Listing Price

    ₹239.00

  • Listing Change

    0.00%

  • Last Traded Price

    ₹224.96

Rays of Belief IPO Details

  • Open Date

    01 Sep 2026

  • Close Date

    03 Sep 2026

  • IPO Price Range

    ₹ 227 to ₹239

  • IPO Size

    ₹ 125 Cr

Open Free Demat Account

+91

By proceeding, you agree to all T&C*

hero_form

Rays of Belief IPO Subscription Status

Last Updated: 03 September 2026 5:33 PM by 5paisa

Rays of Belief Limited is a for-profit social enterprise providing personalised intervention plans for children with neurodevelopmental disorders, including autism, ADHD, cerebral palsy, learning disabilities and developmental delays. Its multidisciplinary services include early intervention, occupational therapy, speech and language therapy, behavioural support, special education, parental guidance and family support. The company primarily serves children aged 18 months to 12 years, with specialised programs extending to 15 years. Since commencing operations in 2018, it has served over 58,000 children and operates 136 centres across 57 Indian cities. 

Established in: 2017 

Managing Director: Nitin Bindlish 

Rays of Belief Objectives

1. Gross proceeds of the Fresh Issue 

2. Less: Issue related expenses to the extent applicable to the Fresh Issue (only 

3. those apportioned to our Company) 

4. Net Proceeds 

Rays of Belief IPO Size 

Types Size
Total IPO Size ₹125 Cr 
Offer For Sale -
Fresh Issue ₹125 Cr 

Rays of Belief IPO Lot Size 

Application Lots Shares Amount (₹)
Retail (Min)   1 62  14,074 
Retail (Max)   13 806  1,92,634 
S-HNI (Min)  14 868  1,97,036 
S-HNI (Max)  67 4,154  9,92,806 
B-HNI (Min)  68 4,216  10,07,624 

Rays of Belief IPO Reservation

Investors Category Subscription (times) Shares Offered* Shares bid for Total Amount (Cr.)*
QIB (Ex Anchor) 9.06 18,30,310 1,65,76,630 396.18
Non-Institutional Buyers 279.11 7,84,500 21,89,64,780 5,233.26
  bNII 303.82 5,23,000 15,88,98,374 3,797.67
 sNII 229.70 2,61,500 6,00,66,406 1,435.59
Retail 195.86 5,23,000 10,24,36,338 2,448.23
Total** 107.71 31,37,810 33,79,77,748 8,077.67

*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.

Profit and Loss

Balance Sheet

Particulars (In ₹ Crores) FY24 FY25 FY26
Revenue 30.8  36.5  8.21 
EBITDA 1.5  11.9 
PAT 0.9  5.9 
Particulars (In ₹ Crores) FY24 FY25 FY26
Total Assets 13  26.1  50.9 
Share Capital 0.3  0.32  15.6 
Total Liabilities 13  26.1  50.9 
Particulars (In ₹Crores.) FY24 FY25 FY26
Net Cash Generated From / (used in) Operating Activities 2.1  -1.8  -1.94 
Net Cash Generated From / (used in) Investing Activities -2.7  -2.04  -6.2 
Net Cash Generated From / (used in) Financing Activities 1.03  4.9  6.03 
Net Increase (Decrease) in Cash and Cash Equivalents 0.4  1.04  -2.08 


Strengths

1. Extensive network across multiple Indian cities 

2. Personalised multidisciplinary neurodevelopmental intervention programmes 

3. Diverse presence across Tier 1–3 cities 

4. Scalable leased-centre model limits upfront investment 

Weaknesses

1. Significant operations conducted from leased premises 

2. Dependence on related parties for export revenue 

3. Negative operating cash flow during FY2026 

4. Client retention remains important for revenue growth 

Opportunities

1. Rising awareness of neurodevelopmental disorders in India 

2. Expansion into new cities and underserved markets 

3. Growing adoption of multidisciplinary developmental care models 

4. Digital health tools can broaden service accessibility 

Threats

1. Shortage of skilled professionals across care industry 

2. Regional disparities may restrict access to services 

3. Regulatory fragmentation could affect industry operations 

4. Social stigma may constrain developmental care adoption

Rays of Belief Limited operates in the growing neurodevelopmental care segment, providing multidisciplinary intervention services for children across India. Its extensive network across multiple cities, personalised intervention programmes and presence across Tier 1, Tier 2 and Tier 3 markets support its reach. The company’s scalable centre model provides scope for further geographical expansion. Rising awareness of neurodevelopmental disorders and increasing demand for specialised child development services may create long-term growth opportunities, while investors should carefully consider the associated business and industry risks. 

1. Rising NDD awareness supports growing intervention demand 

2. Expanding presence across underserved Indian cities 

3. Digital health adoption can improve service accessibility 

4. New centres support wider geographic market penetration 

Upcoming IPOs

View all IPOs
  • Companies
  • Type
  • Opening On

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

FAQs

Rays of Belief IPO opens from September 1, 2026 to September 3, 2026. 

The size of Rays of Belief IPO is ₹125 Cr. 

The price band of Rays of Belief IPO is fixed at ₹227 to ₹239 per share.  

To apply for Rays of Belief IPO, follow the steps given below: 

●    Login to your 5paisa demat account and select the issue in the current IPO section     

●    Enter the number of lots and the price at which you wish to apply for the Rays of Belief IPO.  

●    Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.     

You will receive a mandate notification to block funds in your UPI app.

The minimum lot size of Rays of Belief IPO is of 62 shares and the investment required is ₹14,818. 

The share allotment date of Rays of Belief IPO is September 4, 2026 

The Rays of Belief IPO will likely be listed on September 8, 2026. 

Mefcom Capital Markets Limited is the book running lead manager for Rays of Belief IPO. 

Rays of Belief IPO plans to utilise the raised capital from the IPO for: 

1. Gross proceeds of the Fresh Issue 

2. Less: Issue related expenses to the extent applicable to the Fresh Issue (only 

3. those apportioned to our Company) 

4. Net Proceeds